Generic Drug Manufacturer to Invest $31.3M in Fayetteville Plant

OurPharma of Fayetteville plans to invest $31.3 million in a Fayetteville facility that will develop lower-cost alternatives to generic drugs.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.